EUVIMEDEUVIMED entdecken
Crossref

Metal–Organic Frameworks (MOFs) as Green Catalysts in Pharmaceutical Synthesis

Dr. S. R. Pratap, Dr. M. Sulochana, Dr. N. Baratha Jyothi, Dr. C. Mabel Joshaline, Mrs. M. Krishnaveni, Dr. Aruna Kumari Nakkella

International Journal of Drug Delivery Technology · 08.04.2026 · 16 (03)

DOI: 10.25258/ijddt.16.3.66 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 08.04.2026. Verfasst von Dr. S. R. Pratap und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metal–Organic Frameworks (MOFs) have garnered significant attention as next-generation green catalysts due to their unique structural and physicochemical properties, offering transformative potential in pharmaceutical synthesis. These crystalline porous materials, constructed from metal ions or clusters interconnected by organic linkers, exhibit exceptionally high surface areas, tunable pore architectures, and chemically tailorable functionalities. Such characteristics enable precise modulation of catalytic sites, thereby enhancing activity, selectivity, and substrate specificity in complex organic transformations. From a green chemistry perspective, MOFs present a compelling alternative to conventional catalytic systems by enabling reactions under mild conditions, reducing energy input, and minimizing waste generation. Their heterogeneous nature facilitates easy separation and recyclability, addressing key limitations associated with homogeneous catalysts. Moreover, the ability to incorporate catalytically active sites—such as Lewis acids, Brønsted acids, and redox-active centers—within the MOF framework allows for the design of multifunctional catalysts capable of promoting cascade and tandem reactions, which are highly desirable in the synthesis of active pharmaceutical ingredients (APIs). Recent advances have further expanded the applicability of MOFs through the development of engineered systems, including defect-engineered MOFs, metal nanoparticle-encapsulated frameworks, and enzyme–MOF biocomposites. These innovations have demonstrated remarkable efficiency in key pharmaceutical reactions such as C–C and C–N bond formation, selective oxidation, and asymmetric synthesis, often achieving superior performance compared to traditional catalysts. Additionally, the integration of MOFs into continuous flow systems highlights their potential for scalable and industrially viable green processes. However, challenges related to long-term stability, moisture sensitivity, metal leaching, and large-scale production remain critical barriers to commercialization. Ongoing research efforts are focused on enhancing structural robustness and developing cost-effective synthesis strategies. Overall, MOFs represent a promising frontier in sustainable catalysis, with the potential to significantly advance environmentally benign pharmaceutical manufacturing.

Zitieren

APA

Pratap, D. S. R., Sulochana, D. M., Jyothi, D. N. B., Joshaline, D. C. M., Krishnaveni, M. M., & Nakkella, D. A. K. (2026). Metal–Organic Frameworks (MOFs) as Green Catalysts in Pharmaceutical Synthesis. International Journal of Drug Delivery Technology, 16(03). https://doi.org/10.25258/ijddt.16.3.66

Vancouver

Pratap DSR, Sulochana DM, Jyothi DNB, Joshaline DCM, Krishnaveni MM, Nakkella DAK. Metal–Organic Frameworks (MOFs) as Green Catalysts in Pharmaceutical Synthesis. International Journal of Drug Delivery Technology. 2026;16(03). doi:10.25258/ijddt.16.3.66

BibTeX
@article{Pratap2026,
  author = {Pratap, Dr. S. R. and Sulochana, Dr. M. and Jyothi, Dr. N. Baratha and Joshaline, Dr. C. Mabel and Krishnaveni, Mrs. M. and Nakkella, Dr. Aruna Kumari},
  title = {Metal–Organic Frameworks (MOFs) as Green Catalysts in Pharmaceutical Synthesis},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {03},
  doi = {10.25258/ijddt.16.3.66}
}
Kostenlos starten →